Cargando…
Reversible myelosuppression suspected to be secondary to linezolid in a cat with infected subcutaneous ureteral bypass systems
CASE SUMMARY: A 5-year-old castrated male domestic shorthair cat was presented for a multidrug-resistant Enterococcus faecium urinary tract infection within its bilateral subcutaneous ureteral bypass systems. After considerable consultation, the cat was treated with oral linezolid (10 mg/kg q12h) fo...
Autores principales: | Hedgespeth, Barry A, Tefft, Karen M, Kendall, Allison R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691925/ https://www.ncbi.nlm.nih.gov/pubmed/33282333 http://dx.doi.org/10.1177/2055116920967226 |
Ejemplares similares
-
Subcutaneous ureteral bypass device placement in 81 cats with benign ureteral obstruction (2013‐2018)
por: Wuillemin, Florian, et al.
Publicado: (2021) -
Risk factors for positive urine cultures in cats with subcutaneous ureteral bypass and ureteral stents (2010‐2016)
por: Kopecny, Lucy, et al.
Publicado: (2018) -
Complications of MRSA Treatment: Linezolid-induced Myelosuppression Presenting with Pancytopenia
por: Gorchynski, Julie, et al.
Publicado: (2008) -
A retrospective study of anesthesia for subcutaneous ureteral bypass
placement in cats: 27 cases
por: LUCA, Geneviève C., et al.
Publicado: (2017) -
Risk factors and clinical relevance of positive urine cultures in cats with subcutaneous ureteral bypass
por: Deprey, Julie, et al.
Publicado: (2021)